Dr. Peter Maag | Source | Former President of Novartis Diagnostics and current CEO of CareDX at CareDX

We are delighted to announce this collaboration with Weill Cornell Medicine to help bring UroMap’s rapid allograft rejection detection capabilities to our industry-leading suite of transplant care solutions. We continue our commitment to fund research and drive innovation for transplant patient care.